This browser is not actively supported anymore. For the best passle experience, we strongly recommend you upgrade your browser.
| 1 minute read

Pharma IPR Conference

Axinn is proud to be a Platinum Partner of the Pharma IPR Conference

  • On March 5 at 11:00 AM, partners Aziz Burgy, Ted Mathias, and counsel Rebecca Clegg are excited to conduct a panel discussion covering “Polymorph Patents: Infringement and Invalidity Challenges.” 
  • On March 6 at 10:00 AM, partner Chad Landmon will moderate the “Industry Insights on Hatch-Waxman and Paragraph IV Litigations.

We Know Pharma … and They Know Us

Axinn is the go-to firm for IP matters of strategic importance and offers one of the leading pharmaceutical practices in the country. Our team combines its depth of substantive patent law and litigation experience with FDA and antitrust knowledge to offer clients a unique and holistic offering. Whether leading a patent trial on a blockbuster product or navigating the complex FDA regulatory regime, Axinn enables pharmaceutical clients to bring their products to market in the most profitable manner possible.

We've worked on some of the most successful products in the pharmaceutical industry representing over $30 billion in annual sales, including:

Extensive Pharmaceutical Industry Experience

Contact Us

Please reach out to any of our attorneys attending the conference. You can set up a time to meet with an individual attorney using the email link in their contact details.

Aziz Burgy
Rebecca Clegg
Chad Landmon
Ted Mathias





intellectual property, biosimilars, fda, generics, healthcare, patents, pharma